Valeant Pharmaceuticals International (VRX) reported first quarter adjusted EPS of $1.27 Tuesday morning, down from $2.05 a year ago. Analysts expected EPS of $1.37. Full year adjusted EPS is now expected to be between $6.60 and $7.00, down from prior expectations of $9.50 to $10.50. Street expectations are for EPS of $8.47.
from RTT - Before the Bell http://ift.tt/1WEB688
via IFTTT
No comments:
Post a Comment